key: cord-0829689-tlfcr2hh
authors: Uesako, Hayata; Fujikawa, Hirohisa; Hashimoto, Satoshi; Wakabayashi, Tadamasa
title: Prominent J waves and ventricular fibrillation due to myocarditis and pericarditis after BNT162b2 mRNA COVID-19 vaccination
date: 2022-02-10
journal: Can J Cardiol
DOI: 10.1016/j.cjca.2022.02.005
sha: 24f0f7a7390961f842b19766e2f5ac1c2c250022
doc_id: 829689
cord_uid: tlfcr2hh

nan

2 Summary: We report a case of myocarditis and pericarditis after vaccination with the BNT162b2 vaccine that resulted in J wave syndrome and ventricular fibrillation. This case may provide clues to the mechanism of fatal arrhythmia and sudden death after the BNT162b2 vaccine. Table 1 ). The ST elevation improved within minutes. A notch-type J wave was observed in the inferior and lateral leads, with a mirror image in the anterior leads (Fig. 1B, Table 1 ). Cardiac ultrasound revealed diffuse mild hypokinesis of the left ventricle. Emergency coronary angiography showed no significant stenosis.

Cardiac magnetic resonance imaging (MRI) displayed late gadolinium enhancement (LGE) of the epicardial side of the inferior and lateral walls, indicating the presence of myocarditis and pericarditis ( Fig. 2A, B ). An endomyocardial biopsy of the septal side of the right ventricle, performed on day 8, showed myocardial fibrosis on histology, suggestive of subacute myocarditis (Fig. 2C, D) . Immunohistochemistry revealed CD68-positive histiocyte and CD3-positive lymphocyte infiltrates, with histiocyte predominance (Fig. 2E, F) . Other investigations, including left ventricular angiography, an ergonovine coronary spasm induction test, and a pilsicainide challenge test, showed no remarkable findings. Because his cardiac event occurred 5 days after the vaccination, with no other triggers identified, we suspected that the myocarditis and pericarditis that had led to J wave syndrome and consequent VF was an adverse effect of the BNT162b2 vaccine. We reported it to the Japanese Pharmaceuticals and Medical Devices Agency.

The patient's subsequent clinical course was uneventful. No J waves were observed in any of the leads after the acute phase (Fig. 1C, Table 1 ). After performing various tests, we administered bepridil in order to prevent VF. For secondary prevention, on the 22nd day of hospitalization, he was transferred to another hospital for implantation of a subcutaneous implantable cardioverter defibrillator (S-ICD). After completion of S-ICD implantation, bepridil was discontinued, and the patient is doing well on follow up. Abbreviations: N/A, not applicable * In Fig. 1A , it was difficult to accurately measure the PR interval and QTc interval because P waves and T waves were not clear. 

Proposed diagnostic criteria for the Brugada syndrome: consensus report

Early repolarization in the inferolateral leads: A new syndrome associated with sudden cardiac death

Ventricular fibrillation associated with J-wave manifestation following pericarditis after catheter ablation for paroxysmal atrial fibrillation

Acute myocarditis after COVID-19 vaccination with mRNA-1273 in a patient with former SARS-CoV-2 infection